share_log

Intelligent Bio Solutions | 4: Statement of changes in beneficial ownership of securities-Officer Sakiris Spiro Kevin

Intelligent Bio Solutions | 4:持股变动声明-高管 Sakiris Spiro Kevin

SEC announcement ·  03/21 19:57
Moomoo AI 已提取核心信息
Spiro Kevin Sakiris, the Chief Financial Officer of Intelligent Bio Solutions (INBS), engaged in a stock transaction on March 20, 2024, as per the latest SEC filings. Sakiris acquired 9,394 shares of Intelligent Bio Solutions' common stock indirectly through Anest Holdings Pty Ltd, with the transaction coded as 'X'. Following this acquisition, Sakiris now indirectly holds a total of 19,180 shares. Additionally, he directly holds 314 shares of common stock. The nature of the shares acquired is indirect, and the transaction has increased his total beneficial ownership in the company to 19,494 shares.
Spiro Kevin Sakiris, the Chief Financial Officer of Intelligent Bio Solutions (INBS), engaged in a stock transaction on March 20, 2024, as per the latest SEC filings. Sakiris acquired 9,394 shares of Intelligent Bio Solutions' common stock indirectly through Anest Holdings Pty Ltd, with the transaction coded as 'X'. Following this acquisition, Sakiris now indirectly holds a total of 19,180 shares. Additionally, he directly holds 314 shares of common stock. The nature of the shares acquired is indirect, and the transaction has increased his total beneficial ownership in the company to 19,494 shares.
根据美国证券交易委员会的最新文件,智能生物解决方案(INBS)首席财务官斯皮罗·凯文·萨基里斯于2024年3月20日进行了一次股票交易。萨基里斯通过Anest Holdings Pty Ltd间接收购了Intelligent Bio Solutions的9,394股普通股,该交易编码为 “X”。在这次收购之后,Sakiris现在间接持有总计19,180股股票。此外,他直接持有314股普通股。所收购股份的性质是间接的,该交易使他在公司的总实益所有权增加到19,494股。
根据美国证券交易委员会的最新文件,智能生物解决方案(INBS)首席财务官斯皮罗·凯文·萨基里斯于2024年3月20日进行了一次股票交易。萨基里斯通过Anest Holdings Pty Ltd间接收购了Intelligent Bio Solutions的9,394股普通股,该交易编码为 “X”。在这次收购之后,Sakiris现在间接持有总计19,180股股票。此外,他直接持有314股普通股。所收购股份的性质是间接的,该交易使他在公司的总实益所有权增加到19,494股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息